Dozen weight-loss generics being reviewed for SA | News24
news24.com
منذ ساعتين
South Africa’s health regulator is reviewing 12 applications for generic versions of semaglutide, the active ingredient in Novo Nordisk’s blockbuster diabetes and weight-loss medicines.
